Riskpilot← Back to searchSign inGet full accessRS Fysioterapi AB
ABActiveOrg 5591306013Medvindsgatan 15Physiotherapy activities · NACE 8695Est. 20171 employees
Revenue 2025
SEK 1,2M
-18% vs 2024
EBITDA margin
11.4%
-24% vs 2024
Equity ratio
47.5%
Financial strength
Net profit 2025
SEK 32K
-65% vs 2024
| Revenue | SEK 1,2M | -18% |
| EBITDA | SEK 139K | -24% |
| Net profit | SEK 32K | -65% |
| Total assets | SEK 898K | +47% |
| Equity | SEK 426K | +0% |
| Employees | 1 | — |
Legal name
RS Fysioterapi AB
Org number
5591306013
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
25 oktober 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten i bolaget är fysioterapi-mottagning med remissfri vård för muskeloskelettala besvär.
Address
Medvindsgatan 15
Email
saamaa_@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 445 | 986 | 1 480 | 1 489 | 1 225 |
| Staff expenses | — | −533 | −703 | −770 | −664 |
| EBITDA | 464 | 88 | 307 | 183 | 139 |
| Depreciation & amort. | −111 | −115 | −115 | −115 | −119 |
| EBIT | 353 | −26 | 192 | 69 | 20 |
| Net financials | −27 | −16 | −8 | −1 | −1 |
| Profit before tax | 151 | 107 | 134 | 118 | 44 |
| Tax | −32 | −21 | −33 | −28 | −12 |
| Net profit | 119 | 86 | 101 | 90 | 32 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 988 | 660 | 631 | 611 | 898 |
| Equity | 283 | 309 | 359 | 425 | 426 |
| Long-term debt | 346 | 164 | 31 | 0 | 247 |
| Short-term debt | 59 | 37 | 40 | 37 | 100 |
| Total debt | 405 | 201 | 72 | 37 | 347 |
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
20212025
Equity ratio
47.5%
This company
38.2%
Market median
+24% vs market
20212025
Return on equity
7.4%
This company
18.4%
Market median
-60% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
1.36×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RS Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hampus Öhlin Gouranius | Deputy Board Member | 0 companies |
| Rebecca Samuelsson | Board of Directors | 0 companies |
| Marie Elisabeth Samuelsson | Deputy Board Member | 0 companies |